In autoimmunity, the mechanisms that guarantee that our defense system does not attack our own body - tolerance to oneself - does not work properly. Multiple sclerosis, which affects one in every 1,000 people in Spain, is a serious autoimmune disease in which the immune system attacks the myelin sheath of some types of neurons, causing progressive neurological disability.
The researchers have recently published in the journal Cell Reports the mechanism by which vitamin D activates the tolerance program of dendritic cells.
Dendritic cells are a type of immune cells present in the blood and tissues, capable of detecting potential threats and displaying them to lymphocytes in the lymph nodes. Once there, they decide whether the system is going to tolerate that threat or attack it.
It is known that when dendritic cells are treated with vitamin D they develop tolerogenic characteristics, so treatment with tolerant dendritic cells in multiple sclerosis patients could slow the progression of the disease. A growing number of experiments in animal models support this hypothesis and, as a matter of fact, the Neuroimmunology group is carrying out an international clinical trial to check it in patients with multiple sclerosis. This trial is part of the European-funded project ReSToRe (https://www.h2020restore.eu/).
However, the fact that the mechanism underlying the appearance of this tolerance profile was unknown prevented further insight on this therapeutic approach. The article published in Cell Reports, whose main authors conclude that the binding of the vitamin D receptor with the STAT3 protein results in the activation of TET2, a DNA demethylating agent - a type of epigenetic mark - that, in dendritic cells, promotes the activation of tolerance genes.
Thus, the researchers manage to demonstrate, for the first time, that the relationship between vitamin D and the generation of the tolerance profile of dendritic cells is due to the modification of epigenetic marks by TET2, through the IL-6- JAK-STAT3, very well-known clinical target.
With this new information, a door opens to the use of existing drugs that interfere with the STAT3 pathway and optimize the production of tolerogenic dendritic cells, capable of stopping the progression of multiple sclerosis and other autoimmune diseases. This would be a new example of a promising cellular therapy, such as the CAR-T developed against cancer.
https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01753-8
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fvitamin-d-receptor&filter=22
Vitamin D epigenetically modulates the tolerance of the immune system
- 1,278 views
- Added
Latest News
Tumor infiltration of immun…
By newseditor
Posted 28 May
New light-controlled 'off s…
By newseditor
Posted 28 May
Gene function during embryo…
By newseditor
Posted 28 May
Formation of 3D blood vesse…
By newseditor
Posted 27 May
Liver regeneration during c…
By newseditor
Posted 27 May
Other Top Stories
How exercise increases the efficiency of muscle energy production
Read more
Calcitonin receptor involved in risk taking maternal care
Read more
New clue to treating spinal cord injury
Read more
Prebiotic ethanolamine found in space
Read more
SIRT6 increases life expectancy by an average of 30%
Read more
Protocols
SEMORE: SEgmentation and MO…
By newseditor
Posted 26 May
Spatially resolved lipidomi…
By newseditor
Posted 24 May
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Publications
Advanced microbiome therape…
By newseditor
Posted 29 May
Hippocampal astrocytes indu…
By newseditor
Posted 29 May
TNIK's emerging role in can…
By newseditor
Posted 29 May
Diabetes drugs activate neu…
By newseditor
Posted 29 May
Circadian tumor infiltratio…
By newseditor
Posted 28 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar